Practice
Featured experience
Alphabet $20 billion notes offering
We advised the global coordinators and book-running managers on the offering
Circle $1.05 billion IPO
We are advising Circle on its IPO, the first IPO by a stablecoin issuer
EquipmentShare $860 million IPO
We advised EquipmentShare on its IPO
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
ADTRAN Holdings $201.25 million convertible senior notes offering
The 3.75% convertible senior notes are due 2030
Ferguson $750 million senior notes offering
The investment-grade notes are due 2031
Energizer Holdings $400 million notes offering
The high-yield notes are due 2033
Strive acquisition of Semler Scientific
We are advising Strive on the acquisition
Oruka Therapeutics $180 million private placement
The PIPE included common stock and pre-funded warrants
British American Tobacco $750 million notes offering
The investment-grade notes are due 2033
Grayscale CoinDesk Crypto 5 ETF approved as first U.S. multi-asset crypto ETF
We advised Grayscale on securing SEC approval for the NYSE Arca listing
Applied Materials $1 billion senior notes offering
The investment-grade notes are due 2031 and 2036
GenFleet Therapeutics HK$1.82 billion IPO
We advised GenFleet on its IPO and HKEX listing
Baldwin Group $1.006 billion credit facilities financing
We advised the borrower on the refinancing and amendment